bioRxiv Science⌕ Search

Biology subjects

Trafford, A. W.

Publications and source records attributed to Trafford, A. W..

6 recordsLinked to original sources

Carotid body mitochondria exhibit normal oxygen affinity despite COX4I2 enrichment

The carotid body (CB) is the key peripheral oxygen sensor. CB mitochondria are hypothesised to be uniquely adapted with unusually low intrinsic oxygen affinity which, in association with nitric oxide (NO) and reactive oxygen species signalling, enables acute responsiveness to hypoxia. However, CB mitochondrial physiology or intrinsic oxygen affinity have never been measured directly. We sought to address this key gap by isolating sheep CB mitochondria and comprehensively characterising their phenotype and contrasting them to a non-oxygen sensing tissue, left ventricular myocardium (LV). High resolution respirometry, liquid chromatography mass spectrometry, enzymatic assays and in silico modelling were used to characterise mitochondrial content, aerobic capacity, oxygen affinity, complex subunit abundance and activity, H2O2 production and NO sensitivity in ovine CB and LV. Mitochondrial oxygen affinity (P50 = 0.089 mmHg) was lower in the CB than the LV (P50 = 0.058 mmHg; p = 0.005). Whilst mitochondrial content was lower in the CB, CB mitochondria had higher respiratory rates and enzymatic activity than LV. H2O2 production and NO sensitivity were similar in the two tissues. While intrinsic mitochondrial oxygen affinity is slightly lower in the oxygen sensing CB than in the non-oxygen sensing LV, this difference is small. Hence, any role of mitochondria in CB oxygen sensing is not due to an intrinsic difference in the O2 affinity of cytochrome oxidase due to differential expression of its subunits. Instead, this work suggests that differences in O2 affinity in vivo are secondary to other factors, perhaps including NO, that alter mitochondrial O2 affinity.

physiology↗

Increased calcium spark frequency and variability of action potential duration precede early after depolarisations in isolated ventricular myocytes

Drug-induced inhibition of the delayed rectifier potassium (IKr) current predisposes to early afterdepolarisations (EADs) and cardiac arrhythmias. Here, we sought to determine the contribution of action potential duration (APD), APD variability and spontaneous calcium release from the sarcoplasmic reticulum (SR) in the formation of EADs. In isolated sheep ventricular myocytes, EADs were induced by combined inhibition of IKr with dofetilide and {beta}-adrenergic stimulation. The onset of EADs was preceded by increased beat-to-beat variability of APD. To isolate the role of APD in EAD initiation, the sarcoplasmic reticulum (SR) was depleted of calcium with caffeine. The first beat post-caffeine was associated with prolonged APD but not an EAD. During {beta}-AR stimulation, increasing ryanodine receptor open probability had no effect on APD but increased APD variability and induced both EADs and delayed afterdepolarisations (DADs). Targeting RyR open probability with K201 reversibly abolished afterdepolarisations. APD variability was a better predictor of EADs than APD alone. During an EAD, changes in [Ca2+]i preceded those of membrane depolarisation and the changes in [Ca2+]i were in the form of calcium sparks. In silico modelling demonstrated that membrane time constant effects account for the delay between changes in [Ca2+]i and membrane potential. In summary, using a drug-induced model of action potential prolongation with {beta}-AR stimulation, EADs are preceded by increased APD variability and an increase in Ca2+ sparks. Targeting SR function abolishes EADs. These results suggest a key role for SR Ca2+ overload in the formation of EADs and indicate that EADs and DADs share common mechanisms. Key PointsO_LIDrugs that prolong the cardiac action potential and ECG QT interval are a major cause of early afterdepolarisations and dangerous ventricular arrhythmias initiated by early afterdepolarisations. C_LIO_LIProlongation of the action potential is widely assumed to be the primary driver of these events. C_LIO_LIWe show that early afterdepolarisations are instead preceded by increased beat-to-beat variability of action potential duration and that this variability has better sensitivity and specificity for early afterdepolarisations than action potential duration. C_LIO_LISmall, spontaneous calcium release events known as calcium sparks occur before membrane depolarisation driving early afterdepolarisations. C_LIO_LISuppressing calcium release from the sarcoplasmic reticulum abolishes early afterdepolarisations, identifying calcium handling instability as potentially a key mechanism of drug-induced arrhythmia. C_LI

physiology↗

Dysferlin Regulates Cardiac T-tubule Structure and Excitation-contraction Coupling in Isolated Cardiac Myocytes at Rest and in Response to Acute Hypo-osmotic Stress and is Protective Against Arrhythmias in Langendorff-perfused Hearts

Dysferlin is a membrane-associated protein that supports skeletal muscle function such that mutations in the DYSF gene can cause muscular dystrophy. Growing evidence suggests dysferlin regulates cardiac function, but this is less well understood. Tight regulation of the cardiac transverse-(T)-tubule network and excitation-contraction (EC) coupling mechanism is essential for healthy cardiac physiology. Remodelling of T-tubules and the EC coupling mechanism is observed during periods of cardiac stress and pathologies, promoting arrhythmias. However, little is known about how these processes are regulated and any protective mechanisms which may limit detrimental effects. Using a global dysferlin knockout (KO) mouse we have shown that the loss of dysferlin leads to a decrease in T-tubule density and the amplitude and rate of decay of the systolic Ca2+ transient but a narrowing of the dyadic cleft. Electrical mapping of ex vivo DYSF KO hearts shows they are more susceptible to ventricular arrhythmias. To induce stress, we used hypo-osmotic shock injury (OSI) to damage T-tubule networks in cardiac myocytes, in vitro. OSI increased T-tubule fragmentation and caused dysregulation of intracellular Ca2+ handling in dysferlin KO cells relative to WT controls. Finally, we observed that a natural decline in WT cardiac dysferlin abundance, which may contribute to the natural age-dependent maladaptive T-tubule remodelling that occurs in the mammalian ventricle. In summary, these findings demonstrate an essential role for dysferlin in cardiac physiology, especially during conditions of stress, which is decreased in normal ageing.

physiology↗

Atrial t-tubules adopt a specialist developmental state while alterations to Ca2+ buffering maintain systolic Ca2+ during postnatal development

Transverse (t)-tubules ensure a uniform rise in calcium (Ca2+) and thus contraction in cardiac cells. Though more extensively studied in the ventricle, t-tubules also play a key role in the atria of large mammals, such as human, and their loss in heart failure is associated with impaired Ca2+ release and thus contractility. T-tubule restoration is therefore an ideal therapeutic target but the process of t-tubule formation is not understood. The aim of this study was to determine how t-tubules develop in the healthy atria and the impact this has on Ca2+ handling. Postnatal development was assessed in sheep from newborn through to adulthood. Atrial t-tubules were present at birth in the sheep atria and increased in density up until 3 months of age. In the latter part of development (3 months to adult) a lack of t-tubule growth but increase in cell width results in t-tubule density decreasing. In the newborn, despite reduced t-tubule density, we found the amplitude of the Ca2+ transient was maintained and this was associated with increases in the L-type Ca2+ current (ICa-L) and the Ca2+ content of the sarcoplasmic reticulum (SR). We suggest these changes are sufficient to overcome the elevated cytosolic Ca2+ buffering in the newborn and the decreased t-tubule density. We have shown the neonate atria is highly specialised to negate reduced central Ca2+ release through enhanced surface ICa-L and SR load. This maintains atrial function despite immature t-tubules highlighting important differences in Ca2+ handling in the newborn and heart failure atria where t-tubules are sparse.

physiology↗

Disordered yet functional atrial t-tubules on recovery from heart failure

Transverse (t)-tubules drive the rapid and synchronous Ca2+ rise in cardiac myocytes. The virtual complete loss of atrial t-tubules in heart failure (HF) decreases Ca2+ release. It is unknown if or how atrial t-tubules can be restored and if restored t-tubules are functional. Sheep were tachypaced to induce HF and recovered when pacing was stopped. Serial block face Scanning Electron Microscopy and confocal imaging were used to understand t-tubule ultrastructure and function. Candidate proteins involved in atrial t-tubule recovery were identified by western blot and causality determined using expression studies. Sheep atrial t-tubules reappeared following recovery from HF. Despite being disordered (branched, longer and longitudinally arranged) recovered t-tubules triggered Ca2+ release and were associated with restoration of systolic Ca2+. Telethonin and myotubularin abundance correlated with t-tubule density and altered the density and structure of BIN1-driven tubules in neonatal myocytes. Myotubularin had a greater effect, increasing tubule length and branching, replicating that seen in the recovery atria. Recovery from HF restores atrial t-tubules and systolic Ca2+ and myotubularin facilitates this process. Atrial t-tubule restoration could present a new and viable therapeutic strategy. Brief SummaryThe loss of atrial transverse (t)-tubules and the associated dysfunction in heart failure is reversible and the protein myotubularin plays an important role.

physiology↗

PDE5 inhibition improves symptom-free survival and restores transverse tubule loss and catecholamine responsiveness in heart failure

Heart failure is characterized by poor survival, a loss of catecholamine reserve and cellular structural remodeling in the form of disorganization and loss of the transverse tubule network. Indeed, survival rates for heart failure are worse than many common cancers and have not improved over time. Tadalafil is a clinically relevant drug that blocks phosphodiesterase 5 with high specificity and is used to treat erectile dysfunction. Using a sheep model of advanced heart failure, we show that tadalafil treatment results in a marked improvement in symptom-free survival, reverses transverse tubule loss and restore cardiac myocyte systolic calcium transient amplitude and the hearts chronotropic and contractile response to catecholamines. These effects are independent of changes in myocardial cGMP content and are associated with upregulation of both monomeric and dimerized forms of protein kinase G and of the cGMP hydrolyzing phosphodiesterase 2 and 3. We propose that the molecular switch for the loss of transverse tubules in heart failure and their restoration following tadalafil treatment involves the BAR domain protein Amphiphysin II (BIN1) and the restoration of catecholamine sensitivity is through reductions in G-protein receptor kinase 2, protein phosphatase 1 and protein phosphatase 2A abundance following phosphodiesterase 5 inhibition.

physiology↗